{"id":"adjuvant-folfox","safety":{"commonSideEffects":[{"rate":"30-40%","effect":"Diarrhea"},{"rate":"20-30%","effect":"Neutropenia"},{"rate":"20-30%","effect":"Nausea"},{"rate":"10-20%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Oxaliplatin is a platinum-based chemotherapeutic agent that forms platinum-DNA adducts, thereby inhibiting DNA replication and transcription. 5-fluorouracil is a thymidylate synthase inhibitor that interferes with DNA synthesis.","oneSentence":"Oxaliplatin and 5-fluorouracil inhibit DNA replication and transcription by cross-linking DNA and interfering with thymidylate synthase.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:21:00.669Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Colorectal cancer"}]},"trialDetails":[{"nctId":"NCT02758951","phase":"PHASE2, PHASE3","title":"Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Koen Rovers","startDate":"2017-06-01","conditions":"Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant","enrollment":358},{"nctId":"NCT05733689","phase":"PHASE1","title":"Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2025-06-27","conditions":"Gastroesophageal Adenocarcinoma","enrollment":20},{"nctId":"NCT06996483","phase":"","title":"Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastrointestinal Cancers","status":"RECRUITING","sponsor":"Ankara Etlik City Hospital","startDate":"2025-06-05","conditions":"Gastrointestinal Neoplasms","enrollment":82},{"nctId":"NCT07184047","phase":"","title":"Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2024-01-15","conditions":"Gastrointestinal Cancers, Frailty, Sarcopenia in Elderly","enrollment":72},{"nctId":"NCT01460589","phase":"PHASE3","title":"Early Commencement of Adjuvant Chemotherapy for Colon Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyungpook National University Hospital","startDate":"2013-01-13","conditions":"Colon Cancer","enrollment":303},{"nctId":"NCT05673772","phase":"PHASE2","title":"Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyungpook National University Hospital","startDate":"2020-10-23","conditions":"Rectal Cancer","enrollment":364},{"nctId":"NCT03426904","phase":"PHASE3","title":"Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyungpook National University Hospital","startDate":"2020-10-23","conditions":"Colon Cancer","enrollment":708},{"nctId":"NCT06107920","phase":"PHASE3","title":"Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2024-05-07","conditions":"Colon Cancer","enrollment":232},{"nctId":"NCT05412082","phase":"PHASE1","title":"SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"University of Miami","startDate":"2022-10-05","conditions":"Locally Advanced Rectal Cancer","enrollment":25},{"nctId":"NCT05062317","phase":"PHASE2","title":"ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-04-26","conditions":"Liver Metastases","enrollment":120},{"nctId":"NCT02959879","phase":"PHASE2","title":"Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2017-03-01","conditions":"Resectable Pancreatic Duct Adenocarcinoma","enrollment":153},{"nctId":"NCT05062889","phase":"PHASE2","title":"Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients","status":"SUSPENDED","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2023-05-17","conditions":"Stage II Colon Cancer, Stage III Colon Cancer, HER2-positive Colon Cancer","enrollment":477},{"nctId":"NCT04495088","phase":"PHASE3","title":"Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Ralf Hofheinz","startDate":"2020-09-30","conditions":"Rectal Cancer","enrollment":550},{"nctId":"NCT05855200","phase":"PHASE3","title":"Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2023-08-01","conditions":"Colonic Neoplasms, Neoplasms, Colon","enrollment":892},{"nctId":"NCT07363356","phase":"PHASE2","title":"Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer","status":"NOT_YET_RECRUITING","sponsor":"Eastern Hepatobiliary Surgery Hospital","startDate":"2026-01-30","conditions":"Hepatocellular Carcinoma Resectable","enrollment":56},{"nctId":"NCT07340567","phase":"PHASE3","title":"Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test","status":"NOT_YET_RECRUITING","sponsor":"UNICANCER","startDate":"2026-05-01","conditions":"Colorectal Cancer","enrollment":2450},{"nctId":"NCT07272538","phase":"","title":"Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2023-12-20","conditions":"Gastrointestinal Cancers, Frailty at Older Adults, Chemotherapy","enrollment":84},{"nctId":"NCT07257380","phase":"PHASE2","title":"Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-12-30","conditions":"Gastric / Gastroesophageal Junction Adenocarcinoma","enrollment":90},{"nctId":"NCT06783491","phase":"PHASE3","title":"Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer","status":"NOT_YET_RECRUITING","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2025-12-31","conditions":"Locally Advanced Colorectal Cancer","enrollment":1083},{"nctId":"NCT02967289","phase":"PHASE3","title":"IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2017-03-27","conditions":"Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)","enrollment":792},{"nctId":"NCT06467799","phase":"PHASE2","title":"Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-09-01","conditions":"Hepatocellular Carcinoma, Beyond Milan Criteria","enrollment":39},{"nctId":"NCT07188025","phase":"PHASE3","title":"ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2025-10","conditions":"Rectal Cancer","enrollment":103},{"nctId":"NCT05024097","phase":"PHASE2","title":"A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-03-31","conditions":"Rectal Cancer","enrollment":43},{"nctId":"NCT06031285","phase":"PHASE2","title":"Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-09-01","conditions":"Hepatocellular Carcinoma","enrollment":43},{"nctId":"NCT06719362","phase":"PHASE1","title":"A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies","status":"RECRUITING","sponsor":"Providence Health & Services","startDate":"2025-06-17","conditions":"Advanced Solid Tumors","enrollment":110},{"nctId":"NCT05775146","phase":"PHASE2","title":"SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-06-18","conditions":"Colorectal Cancer, Liver Metastasis Colon Cancer","enrollment":24},{"nctId":"NCT06057831","phase":"PHASE2","title":"PET/MRI in Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-05","conditions":"Rectal Cancer","enrollment":40},{"nctId":"NCT06972498","phase":"PHASE2","title":"A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets","status":"NOT_YET_RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2025-07-01","conditions":"Colorectal Cancer With Liver Metastasis","enrollment":35},{"nctId":"NCT06293625","phase":"PHASE3","title":"Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2024-06-07","conditions":"Colon Cancer","enrollment":150},{"nctId":"NCT00059930","phase":"PHASE1","title":"Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-01","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":38},{"nctId":"NCT06844409","phase":"","title":"Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Impact on Quality of Life","status":"COMPLETED","sponsor":"P. Herzen Moscow Oncology Research Institute","startDate":"2021-03-19","conditions":"Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":54},{"nctId":"NCT03255434","phase":"PHASE2","title":"LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2017-11-01","conditions":"Stage III Colon Cancer","enrollment":160},{"nctId":"NCT02000050","phase":"PHASE2","title":"Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)","status":"COMPLETED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2013-10-11","conditions":"Rectal Carcinoma","enrollment":52},{"nctId":"NCT06475352","phase":"PHASE2","title":"Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme","status":"RECRUITING","sponsor":"UNICANCER","startDate":"2025-01-20","conditions":"Digestive Cancer, Colorectal Cancer","enrollment":400},{"nctId":"NCT06758830","phase":"PHASE2, PHASE3","title":"Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.","status":"RECRUITING","sponsor":"National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos","startDate":"2025-01-07","conditions":"Rectal Cancer, Total Neoadjuvant Treatment, Neoadjuvant Therapy","enrollment":400},{"nctId":"NCT02843191","phase":"PHASE3","title":"Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyung Hee University Hospital at Gangdong","startDate":"2016-12-07","conditions":"Rectal Cancer","enrollment":358},{"nctId":"NCT05534087","phase":"PHASE3","title":"Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2022-12-15","conditions":"Colon Cancer","enrollment":236},{"nctId":"NCT06520683","phase":"PHASE3","title":"Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-11-01","conditions":"Colorectal Cancer, Microsatellite Instability High","enrollment":180},{"nctId":"NCT00807911","phase":"PHASE2","title":"Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2008-11-01","conditions":"Rectal Cancer","enrollment":322},{"nctId":"NCT04679597","phase":"","title":"Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2016-01-01","conditions":"Rectal Cancer","enrollment":161},{"nctId":"NCT05496491","phase":"NA","title":"Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Larissa University Hospital","startDate":"2022-08-30","conditions":"Rectal Neoplasms","enrollment":84},{"nctId":"NCT04488159","phase":"PHASE3","title":"Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer","status":"WITHDRAWN","sponsor":"Johannes Laengle, MD, PhD","startDate":"2024-12-01","conditions":"Colon Cancer Stage III","enrollment":""},{"nctId":"NCT06564103","phase":"","title":"Stratification for F-L Therapy After LT","status":"COMPLETED","sponsor":"Xiao Xu","startDate":"2024-01-01","conditions":"Liver Transplantation, Adjuvant FOLFOX Plus Lenvatinib, Machine Learning","enrollment":1},{"nctId":"NCT01274962","phase":"PHASE2","title":"A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer","status":"COMPLETED","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2009-11","conditions":"Operable T2-3N+M0 Rectal Cancer (Stage III)","enrollment":180},{"nctId":"NCT06409637","phase":"PHASE1, PHASE2","title":"FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-01-01","conditions":"Liver Cancer, Liver Transplant","enrollment":62},{"nctId":"NCT00838578","phase":"PHASE1, PHASE2","title":"Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer","status":"TERMINATED","sponsor":"Kyowa Kirin Co., Ltd.","startDate":"2009-03","conditions":"Colorectal Cancer","enrollment":65},{"nctId":"NCT06296563","phase":"PHASE2","title":"Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC","status":"RECRUITING","sponsor":"Lei ZHAO","startDate":"2024-03-01","conditions":"Intrahepatic Cholangiocarcinoma","enrollment":20},{"nctId":"NCT04308837","phase":"PHASE2","title":"A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation","status":"UNKNOWN","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2018-12-03","conditions":"Gastric Cancer, Stomach Cancer","enrollment":29},{"nctId":"NCT01307956","phase":"PHASE2","title":"Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2011-02-28","conditions":"Adenocarcinoma of the Gastroesophageal Junction, Esophageal Adenocarcinoma, Stage IIA Esophageal Cancer","enrollment":11},{"nctId":"NCT00958737","phase":"PHASE3","title":"Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer","status":"UNKNOWN","sponsor":"GERCOR - Multidisciplinary Oncology Cooperative Group","startDate":"2009-05-12","conditions":"Colorectal Cancer","enrollment":2000},{"nctId":"NCT06043999","phase":"NA","title":"Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-09-01","conditions":"Chemotherapy Effect, Rectal Cancer","enrollment":392},{"nctId":"NCT00994864","phase":"NA","title":"Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer","status":"COMPLETED","sponsor":"Jules Bordet Institute","startDate":"2009-11","conditions":"Colon Cancer","enrollment":235},{"nctId":"NCT05832398","phase":"NA","title":"Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2023-05-01","conditions":"Colorectal Cancer","enrollment":186},{"nctId":"NCT04962958","phase":"PHASE2","title":"Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-07-01","conditions":"Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms","enrollment":30},{"nctId":"NCT05797467","phase":"PHASE3","title":"Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2023-04-01","conditions":"Colorectal Cancer, Chemotherapy Effect","enrollment":366},{"nctId":"NCT02974556","phase":"PHASE3","title":"Proactive Management of Endoperitoneal Spread in Colonic Cancer","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2024-03-01","conditions":"Colon Cancer, Intraperitoneal Rectal Cancer","enrollment":140},{"nctId":"NCT05815082","phase":"PHASE3","title":"ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2023-02-20","conditions":"Colorectal Cancer, Liver Metastases, Circulating Tumor Cell","enrollment":490},{"nctId":"NCT05797077","phase":"PHASE3","title":"Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2023-02-20","conditions":"Colorectal Cancer, Liver Metastases, Circulating Tumor Cell","enrollment":346},{"nctId":"NCT05753163","phase":"PHASE2","title":"Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2022-08-02","conditions":"Colorectal Liver Metastasis","enrollment":44},{"nctId":"NCT01558921","phase":"PHASE3","title":"Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2011-06-21","conditions":"Rectal Cancer","enrollment":920},{"nctId":"NCT03883802","phase":"PHASE2","title":"Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer","status":"UNKNOWN","sponsor":"WntResearch AB","startDate":"2019-04-12","conditions":"Colon Cancer","enrollment":100},{"nctId":"NCT01212822","phase":"PHASE2","title":"Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer","status":"COMPLETED","sponsor":"Fox Chase Cancer Center","startDate":"2011-04-27","conditions":"Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach","enrollment":20},{"nctId":"NCT02022033","phase":"PHASE2","title":"BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial","status":"COMPLETED","sponsor":"Brown University","startDate":"2014-02-01","conditions":"Pancreatic Cancer","enrollment":25},{"nctId":"NCT04176952","phase":"PHASE2","title":"PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer","status":"TERMINATED","sponsor":"Judith Dixon-Hughes","startDate":"2019-03-05","conditions":"Neoplasms Pancreatic","enrollment":31},{"nctId":"NCT05378919","phase":"PHASE2","title":"Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Lithuanian University of Health Sciences","startDate":"2015-06-01","conditions":"Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX","enrollment":250},{"nctId":"NCT03957733","phase":"PHASE2, PHASE3","title":"Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.","status":"UNKNOWN","sponsor":"King Abdullah Medical City","startDate":"2017-11-23","conditions":"Rectal Cancer","enrollment":338},{"nctId":"NCT05311319","phase":"PHASE2","title":"HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2022-01-11","conditions":"Hepatocarcinoma","enrollment":70},{"nctId":"NCT01150045","phase":"PHASE3","title":"Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery","status":"UNKNOWN","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-06","conditions":"Colorectal Cancer","enrollment":2527},{"nctId":"NCT05274945","phase":"PHASE2","title":"Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2020-01-01","conditions":"Rectal Cancer","enrollment":58},{"nctId":"NCT03748680","phase":"PHASE2","title":"IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer","status":"UNKNOWN","sponsor":"Karen-Lise Garm Spindler","startDate":"2018-10-01","conditions":"Colorectal Cancer, Circulating Tumor DNA, Adjuvant Chemotherapy","enrollment":64},{"nctId":"NCT03939962","phase":"PHASE2","title":"Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma","status":"UNKNOWN","sponsor":"Henan Cancer Hospital","startDate":"2019-07-24","conditions":"Gastric Cancer","enrollment":60},{"nctId":"NCT05194878","phase":"PHASE3","title":"Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-12-01","conditions":"Colon Cancer Stage II, Colon Cancer Stage III","enrollment":840},{"nctId":"NCT04889820","phase":"NA","title":"Outcome of Neoadjuvant Chemotherapy for Obstructive Colon Cancer","status":"NOT_YET_RECRUITING","sponsor":"The Catholic University of Korea","startDate":"2021-11-01","conditions":"Colon Cancer, Obstruction","enrollment":204},{"nctId":"NCT02231086","phase":"PHASE3","title":"Adjuvant HIPEC in High Risk Colon Cancer","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2015-03","conditions":"Colorectal Neoplasms, Peritoneal Neoplasms","enrollment":204},{"nctId":"NCT04997837","phase":"PHASE3","title":"Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma","status":"RECRUITING","sponsor":"Fudan University","startDate":"2021-07-21","conditions":"Gastric Cancer","enrollment":433},{"nctId":"NCT02167321","phase":"PHASE2","title":"Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2014-12","conditions":"Locally Advanced Rectal Cancer","enrollment":90},{"nctId":"NCT03542136","phase":"NA","title":"Peripheral Neuropathy in Colorectal Cancer Patients Under Adjuvant Chemotherapy With FOLFOX, FLOX or XELOX Regime","status":"COMPLETED","sponsor":"Lund University Hospital","startDate":"2018-06-04","conditions":"Colorectal Cancer","enrollment":30},{"nctId":"NCT02135887","phase":"","title":"A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.","status":"UNKNOWN","sponsor":"Microbio Co Ltd","startDate":"2013-11-04","conditions":"Stage III Colorectal Cancer, Neutropenia","enrollment":184},{"nctId":"NCT00265811","phase":"PHASE3","title":"Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery","status":"COMPLETED","sponsor":"Federation Francophone de Cancerologie Digestive","startDate":"2005-11","conditions":"Colorectal Cancer","enrollment":2559},{"nctId":"NCT03515941","phase":"EARLY_PHASE1","title":"Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers","status":"TERMINATED","sponsor":"Tannaz Armaghany","startDate":"2018-06-22","conditions":"Gastrointestinal Cancer","enrollment":6},{"nctId":"NCT04145193","phase":"PHASE2","title":"Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC","status":"WITHDRAWN","sponsor":"MedImmune LLC","startDate":"2020-10-01","conditions":"Microsatellite-stable Colorectal Cancer","enrollment":""},{"nctId":"NCT04303429","phase":"PHASE3","title":"Adjuvant Chemotherapy in High Risk Stage II Colon Cancer","status":"UNKNOWN","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2020-08","conditions":"Stage II Colon Cancer, Adjuvant Chemotherapy","enrollment":962},{"nctId":"NCT00541112","phase":"PHASE2","title":"Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery","status":"TERMINATED","sponsor":"UNICANCER","startDate":"2007-10-29","conditions":"Colorectal Cancer","enrollment":19},{"nctId":"NCT02425683","phase":"PHASE2","title":"Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX","status":"TERMINATED","sponsor":"US Oncology Research","startDate":"2015-03-26","conditions":"Colorectal Neoplasms, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum","enrollment":24},{"nctId":"NCT04198051","phase":"NA","title":"The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Dalian Medical University","startDate":"2019-12-20","conditions":"Gastric Cancer, Colon Cancer","enrollment":120},{"nctId":"NCT03788226","phase":"PHASE3","title":"A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer","status":"UNKNOWN","sponsor":"Fujian Cancer Hospital","startDate":"2019-02-01","conditions":"Gastric Cancer Stage III","enrollment":600},{"nctId":"NCT01092481","phase":"PHASE3","title":"Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2010-01-26","conditions":"Colon Cancer","enrollment":1580},{"nctId":"NCT03925662","phase":"PHASE3","title":"Mebendazole as Adjuvant Treatment for Colon Cancer","status":"RECRUITING","sponsor":"Sherief Abd-Elsalam","startDate":"2019-04-01","conditions":"Colorectal Cancer","enrollment":40},{"nctId":"NCT03899870","phase":"","title":"Factors Predicting Recurrence in Rectal Cancer After Surgery","status":"COMPLETED","sponsor":"ammar houssem","startDate":"2000-01-01","conditions":"Rectal Cancer, Rectal Adenocarcinoma","enrollment":188},{"nctId":"NCT03422601","phase":"","title":"Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment","status":"UNKNOWN","sponsor":"GERCOR - Multidisciplinary Oncology Cooperative Group","startDate":"2017-07-13","conditions":"Colorectal Cancer, Stage III Colon Cancer","enrollment":1122},{"nctId":"NCT01775254","phase":"","title":"The Inland Northwest Colon Cancer Survivor's Study","status":"COMPLETED","sponsor":"Washington State University","startDate":"2013-01","conditions":"Colon Cancer","enrollment":25},{"nctId":"NCT01540344","phase":"PHASE2","title":"Combined Anticancer Treatment of Advanced Colon Cancer","status":"TERMINATED","sponsor":"University of Regensburg","startDate":"2010-10","conditions":"Peritoneal Carcinomatosis, Colorectal Cancer Metastatic","enrollment":26},{"nctId":"NCT00831181","phase":"PHASE2","title":"Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer","status":"COMPLETED","sponsor":"Beth Israel Medical Center","startDate":"2004-07","conditions":"Colorectal Cancer","enrollment":27},{"nctId":"NCT00832299","phase":"PHASE2","title":"Neo-Adjuvant FOLFOX for Rectal Carcinoma","status":"TERMINATED","sponsor":"Beth Israel Medical Center","startDate":"2009-01","conditions":"Rectal Neoplasms","enrollment":2},{"nctId":"NCT01308086","phase":"PHASE3","title":"Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer","status":"UNKNOWN","sponsor":"Hellenic Oncology Research Group","startDate":"2010-10","conditions":"CRC","enrollment":2000},{"nctId":"NCT01646554","phase":"PHASE2, PHASE3","title":"Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases","status":"WITHDRAWN","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2012-12","conditions":"Colorectal Cancer Metastatic, Liver Metastases, KRAS Mutated Colorectal Cancer","enrollment":""},{"nctId":"NCT02577263","phase":"","title":"Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer","status":"UNKNOWN","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2015-04","conditions":"Stomach Neoplasms","enrollment":64},{"nctId":"NCT01749956","phase":"PHASE2","title":"5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer","status":"COMPLETED","sponsor":"SCRI Development Innovations, LLC","startDate":"2013-01","conditions":"Rectal Cancer","enrollment":39},{"nctId":"NCT00537823","phase":"PHASE2","title":"Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2007-06","conditions":"Colorectal Cancer, Metastases","enrollment":9},{"nctId":"NCT02738697","phase":"PHASE3","title":"Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-01","conditions":"Carcinoma, Hepatocellular","enrollment":290}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":167,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fluorouracil, oxaliplatin, leucovorin"],"phase":"phase_2","status":"active","brandName":"Adjuvant FOLFOX","genericName":"Adjuvant FOLFOX","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adjuvant FOLFOX is a treatment for various conditions, including colon cancer, intraperitoneal rectal cancer, peritoneal carcinomatosis, colorectal cancer metastatic, and curatively resected stage III colon cancer. The treatment involves standard adjuvant systemic chemotherapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}